These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3671181)

  • 1. [Health policies with regard to decreasing cardiovascular disease mortality rate].
    Sterkowicz S
    Pol Tyg Lek; 1987 Jun; 42(26):820-4. PubMed ID: 3671181
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in cardiovascular epidemiology since 1950.
    Feinleib M
    Bull N Y Acad Med; 1984 Jun; 60(5):449-64. PubMed ID: 6587924
    [No Abstract]   [Full Text] [Related]  

  • 3. Socioeconomic inequalities in cardiovascular disease mortality; an international study.
    Mackenbach JP; Cavelaars AE; Kunst AE; Groenhof F
    Eur Heart J; 2000 Jul; 21(14):1141-51. PubMed ID: 10924297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [20 years of cardiovascular epidemiology. The epidemiologist's viewpoint].
    Kornitzer M
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):563-76. PubMed ID: 9005492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors in Croatia: struggling to provide the evidence for developing policy recommendations.
    Kern J; Strnad M; Coric T; Vuletic S
    BMJ; 2005 Jul; 331(7510):208-10. PubMed ID: 16037458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community based cardiovascular risk reduction programs.
    Pearson TA; Boekeloo BO; Graziano S
    Md Med J; 1988 Nov; 37(11):836-9. PubMed ID: 3185155
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases].
    Wilhelmsen L; Wedel H; Conroy R; Fitzgerald T
    Lakartidningen; 2004 May; 101(20):1798-801. PubMed ID: 15198087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of cardiovascular diseases].
    Hate O
    Soins Cardiol; 1984; (18-19):49-59. PubMed ID: 6569731
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of the elaboration and realization of preventing cardiovascular diseases in the USSR].
    Oganov RG; Glazunov IS; Chazova LV; Baubinene AV
    Vestn Akad Med Nauk SSSR; 1985; (12):48-53. PubMed ID: 4090665
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular diseases--United States, Canada, and Western Europe.
    Stat Bull Metropol Life Insur Co; 1980; 61(4):8-12. PubMed ID: 7210039
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease in women: the unsung villain.
    Dallessio KM
    Bus Health; 2001 Oct; 19(9 Suppl A):6-10. PubMed ID: 11699347
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on regional variation in cardiovascular mortality within Europe.
    Müller-Nordhorn J; Binting S; Roll S; Willich SN
    Eur Heart J; 2008 May; 29(10):1316-26. PubMed ID: 18256043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia as a risk factor at elderly age.
    Wenger NK
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):4-9. PubMed ID: 15133423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health impact monitoring.
    Test K
    WHO Reg Publ Eur Ser; 1991; 34():25-38. PubMed ID: 1750978
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of socioeconomic, behavioral and clinical risk factors on mortality.
    Rask K; O'Malley E; Druss B
    J Public Health (Oxf); 2009 Jun; 31(2):231-8. PubMed ID: 19279019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 19. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.